Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1
NCT03610022
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Basal Cell Carcinoma
Locally Advanced Basal Cell Carcinoma
Interventions
DRUG:
Treatment with vismodegib
Sponsor
University Hospital, Bordeaux